A FeNO test (Fractional Exhaled Nitric Oxide test) is a simple, non-invasive breathing test that measures the level of nitric oxide in your breath. Nitric oxide is a gas produced by cells in the lungs, and elevated levels indicate airway inflammation, specifically the type of inflammation associated with asthma.
When airways become inflamed, the cells lining the bronchial tubes produce increased amounts of nitric oxide. By measuring this gas in exhaled breath, doctors can assess the degree of airway inflammation, confirm an asthma diagnosis, predict response to treatment, and monitor disease control over time.
At Dr. Raju's Allergy Centre, we utilise advanced FeNO testing technology to provide objective, quantitative measurements of airway inflammation. This test complements traditional lung function tests like spirometry, offering a complete picture of your respiratory health.
FeNO testing has revolutionised asthma management by providing an objective measure of airway inflammation. Unlike other tests that assess lung function (how well air moves), FeNO assesses the underlying inflammation that drives asthma symptoms.
The Science: Nitric oxide is produced by epithelial cells lining the airways. The enzyme inducible nitric oxide synthase (iNOS) produces nitric oxide in response to inflammation, particularly eosinophilic inflammation in allergic asthma. When asthma is well-controlled, FeNO levels typically decrease.
The Procedure: You are seated; take a deep breath through a filter; exhale steadily into a mouthpiece at a specific flow rate (typically 50 mL/second) for 10 seconds; the analyser measures nitric oxide; results within minutes.
What Makes FeNO Unique: Non-invasive (no needles, no radiation); patient-friendly (adults and children 4–5 years); quick (5–10 minutes); reproducible; immediate results.
FeNO levels are measured in parts per billion (ppb). Interpretation depends on age, symptoms, and clinical context.
| FeNO Level (ppb) | Interpretation | Clinical Significance |
|---|---|---|
| < 25 ppb | Normal | Eosinophilic inflammation unlikely |
| 25 – 50 ppb | Intermediate | Possible inflammation; interpret with caution |
| > 50 ppb | Elevated | Eosinophilic inflammation likely |
| FeNO Level (ppb) | Interpretation | Clinical Significance |
|---|---|---|
| < 20 ppb | Normal | Eosinophilic inflammation unlikely |
| 20 – 35 ppb | Intermediate | Possible inflammation; interpret with caution |
| > 35 ppb | Elevated | Eosinophilic inflammation likely |
Elevated FeNO: Active eosinophilic inflammation; likely steroid responsiveness; poorly controlled asthma; allergic phenotype; possible non-adherence or poor inhaler technique; ongoing allergen exposure.
Normal FeNO: Absence of eosinophilic inflammation; non-eosinophilic phenotype; well-controlled asthma; good adherence; or alternative diagnosis.
1. Diagnosing Asthma: Confirms diagnosis when spirometry is normal but symptoms suggest asthma; useful when patients cannot perform spirometry; differentiates from vocal cord dysfunction, chronic cough, COPD.
2. Predicting Response to Inhaled Corticosteroids: High FeNO (>50 ppb): excellent likelihood of response; Intermediate (25–50 ppb): trial warranted; Low (<25 ppb): unlikely to respond; alternative treatments may be better.
3. Monitoring Asthma Control: Rising FeNO: worsening control or impending exacerbation; stable/decreasing: good control; persistently high despite steroids: adherence or technique issues.
4. Assessing Treatment Adherence: Elevated FeNO despite prescribed steroids suggests non-adherence; normalisation after directly observed therapy confirms it.
5. Phenotyping Asthma: Identifies eosinophilic phenotype—responds well to inhaled steroids; may benefit from biologic therapies.
6. Predicting Exacerbations: Rising FeNO may precede attacks by weeks, allowing early intervention.
Before the Test (3 hours): Avoid foods high in nitrates—leafy greens (spinach, lettuce, kale), beetroot, cured meats (bacon, ham, salami), processed foods with nitrates/nitrites.
1 Hour Before: No smoking, alcohol, caffeine, or strenuous exercise. Continue regular medications unless instructed otherwise.
What to Bring: Doctor's referral, insurance information, medication list, previous FeNO results, questions for the doctor.
Seated comfortably; technician explains and demonstrates; deep breath through filter; steady exhalation into mouthpiece for ~10 seconds; device provides feedback for correct flow; 2–3 attempts for reproducibility. Appointment: 10–15 minutes. You may feel mild lightheadedness; no pain. Children tolerate it well with coaching.
Diagnostic: Suspected asthma when diagnosis is uncertain; chronic cough; symptoms with normal spirometry; differentiating asthma from other conditions.
Monitoring: Confirmed asthma for control assessment; on inhaled corticosteroids; frequent exacerbations; poor response to medications; assessing adherence; pre-school wheezing.
Increase FeNO: Eosinophilic inflammation, allergic asthma, atopy, allergen exposure, viral infections, uncontrolled asthma, non-adherence, eosinophilic bronchitis.
Decrease FeNO: Inhaled or systemic corticosteroids, smoking, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia, pulmonary hypertension, acute alcohol ingestion.
| Test | What It Measures | Advantages | Limitations |
|---|---|---|---|
| FeNO | Airway inflammation | Non-invasive, quick, predicts steroid response | Affected by diet, smoking; not all phenotypes have elevated FeNO |
| Spirometry | Airflow obstruction | Gold standard; severity assessment | Requires effort; normal between exacerbations |
| Peak Flow | Maximum expiratory flow | Portable, home monitoring | Effort-dependent; variable technique |
| Methacholine Challenge | Airway hyperresponsiveness | Highly sensitive for asthma | Time-consuming; induces symptoms |
| Blood Tests | Eosinophil count, IgE | Easy to obtain | Indirect; not lung-specific |
Advantages: Non-invasive, painless; minimal cooperation (4–5 years); helps diagnose when symptoms are non-specific; predicts steroid response; monitors adherence; identifies those who may outgrow asthma.
Indications: Chronic cough, wheezing, exercise-induced symptoms, family history of asthma/allergy, poorly controlled "asthma," differentiating viral wheeze from allergic asthma.
Is it painful? No. You breathe into a mouthpiece while the device measures nitric oxide.
How long? 10 seconds per attempt; 2–3 attempts; entire appointment 10–15 minutes.
Referral? Yes. Bring prescription or referral.
Can I eat? Avoid nitrate-rich foods (leafy greens, beetroot, cured meats) 3 hours before.
Medications? Continue unless instructed otherwise. Inform technician of all medications.
How often? Initial: once; poorly controlled: every 2–3 months; stable: every 6–12 months.
Diagnose all asthma types? FeNO detects eosinophilic inflammation (most allergic asthma). Non-eosinophilic asthma may have normal FeNO; used with other tests.
Normal FeNO but asthma symptoms? Some phenotypes (neutrophilic, paucigranulocytic) don't elevate FeNO. Doctor will consider context.
Insurance? Most plans cover medically necessary FeNO testing.
Dr. Raju CH will: review results; correlate with symptoms; integrate with spirometry and allergy testing; confirm or refine diagnosis; adjust treatment (high FeNO: start/increase inhaled steroids; low FeNO with symptoms: consider alternatives; rising FeNO: address adherence/technique or step up); develop management plan; schedule follow-up.
"FeNO testing has transformed asthma management by bringing objectivity to the assessment of airway inflammation. This simple, non-invasive test helps us identify the right patients for anti-inflammatory therapy, optimise medication dosing, and monitor treatment effectiveness – all with the goal of achieving better asthma control and improving quality of life."
If you have asthma or unexplained respiratory symptoms, expert help is just a call away. Dr. Raju CH provides comprehensive FeNO testing with accurate interpretation and personalised treatment planning.
Email: info@drrajuchesthospital.com | Plot No. 10, Beside Vivid Diagnostics, Chandanagar, Hyderabad - 500050